Efficacy of Aminophylline in Addition to Nebulized Beta-Agonists and Corticosteroid in Treatment of Acute Childhood Asthma.
- Author:
Young Ho RAH
1
;
Chong Woo BAE
;
Sa Jun CHUNG
;
Yong Mook CHOI
Author Information
1. Department of Pediatrics, Kyung Hee University, College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Acute asthma;
Aminophylline;
Children
- MeSH:
Abdominal Pain;
Administration, Oral;
Albuterol;
Aminophylline*;
Asthma*;
Child;
Continental Population Groups;
Hospitalization;
Humans;
Incidence;
Methylprednisolone;
Pediatrics;
Respiratory Rate;
Theophylline
- From:Pediatric Allergy and Respiratory Disease
1998;8(1):98-105
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To determine if intravenous aminophylline adds any efficacy to nebulized albuterol and intravenously administered corticosteroid in children who hospitalized with mild to moderate asthma. METHOD: Subjects were children between the ages of 5 and 15 years admitted of acute asthma attack to Department of Pediatrics, Kyung Hee University Hospital. All patient received therapy with albuterol delivered with nebulization at 4-6 hour interval and intravenously adminstered methylprednisolone in standardized doses. Thirty patients were recruited to receive either an intravenous aminophylline(n=15) or not(n=15). The outcome variables were:duration of hospitalization, percent of predicted peak expiratory flow rates recorded at 12-hour intervals and side effects. When intravenously administered medications were discontinued, therapy continued with oral administration of theophylline. Twice daily assessments of clinical asthma symptoms were made by using a scoring system consisting of respiratory rate, wheeze and accessory muscle use. RESULTS: 1) There were no significant differences at study entry in age, sex, race, number of previous hospital admission, clinical symptom scores, or initial peak flow rates for the two groups. 2) Fifteen patients in the aminophylline group were hospitalized for an mean duration of 5.1+/-1.0 days, whereas 15 patients in the control group required 5.3+/-1.2 days. There were no significant differences between the two groups. 3) There was no differences in the absolute changes in their scores two scoring intervals(at 24 hours) between the two groups. 4) The two groups showed no differences in measurements of peak expiratory flow rates at any time interval and at the end of treatment. 5) The mean theophylline level for aminophylline group was 10.2+/-1.7micorgram/mL. 6) In the aminophylline group, 6 of 15 patients who entered the study experienced adverse effects consisting of nausea/vomiting, abdominal pain, and irritability. Five of 15 patients in the control group had an adverse effects. There were no significant differences between the two groups for incidence of adverse effects. 7) There were no significant differences between the two groups for amount of albuterol therapy required. CONCLUSION: When the combination of systemically administered corticosteroid and inhaled albuterol is used in hospitalized asthmatic children with mild to moderate asthma, addition of theophylline provided no additional benefit. Further study will be needed to evaluate if patients with more severe asthma exacerbation benefit for the use of intraveously administered aminophylline.
